Jodie Lockhart is named as a lobbyist on federal disclosure filings for 72 clients through Jeffrey J. Kimbell & Associates, Inc.. The most recent filing naming them posted in March 2026. Issues reported include Health Issues, Medicare/Medicaid, Defense and Trade (domestic/foreign).
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| BIOTISSUE | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| LIVANOVA USA INC | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Environment/Superfund, Medicare/Medicaid, Veterans |
| WE WORK FOR HEALTH | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid |
| STERIS CORPORATION | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Environment/Superfund, Manufacturing, Disaster Planning/Emergencies |
| ORGANON & CO. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| MEDICAL DEVICE MANUFACTURERS ASSOCIATION | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| SUPERNUS PHARMACEUTICALS INC | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| PHARMING HEALTHCARE, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| COLLEGIUM PHARMACEUTICAL | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| MOMENTOUS | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Defense |
| ILLUMINA, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues, Medicare/Medicaid, Defense |
| SCPHARMACEUTICALS, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues, Veterans |
| ACCURAY INCORPORATED | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Manufacturing, Medicare/Medicaid, Health Issues |
| GLAUKOS CORPORATION (FKA AVEDRO, INC.) | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues, Copyright/Patent/Trademark |
| TERUMO BCT | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues, Trade (domestic/foreign) |
| NEUROTECH PHARMACEUTICALS | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| AMGEN INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| SPARC | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| NEVRO CORPORATION | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid |
| ASTELLAS PHARMA US | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| BIOGEN INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| GILEAD SCIENCES, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| BROOKDALE SENIOR LIVING INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Housing, Health Issues |
| CATALYST PHARMACEUTICALS | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| HARMONY BIOSCIENCES, LLC | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| ARDELYX, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| THE ALLERGY, ASTHMA & SINUS CENTER | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| TENNESSEE RURAL HEALTH IMPROVEMENT ASSOCIATION (FKN TENNESSEE FARM BR. ASSN.) | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| U.S. RENAL CARE | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues, Disaster Planning/Emergencies |
| SSI GROUP | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| THERAGEN, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid |
| AURION BIOTECH | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| SPARK THERAPEUTICS, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Insurance, Medicare/Medicaid, Health Issues |
| EAGLE PHARMACEUTICALS INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| ANIVIVE LIFESCIENCES | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2024 | Medical/Disease Research/Clinical Labs, Health Issues, Agriculture |
| MASIMO | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2024 | Financial Institutions/Investments/Securities |
| REVANCE THERAPEUTICS INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q2 2024 | Health Issues |
| LIFEWARD (FORMERLY REWALK ROBOTICS, INC.) | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q2 2024 | Medicare/Medicaid |
| TEK84 | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q1 2024 | Manufacturing, Science/Technology, Tariff (miscellaneous tariff bills) |
| SUMITOMO PHARMA CO., LTD. (FORMERLY SUNOVION PHARMACEUTICALS, INC.) | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q1 2024 | Medicare/Medicaid, Health Issues |
| ENZYVANT THERAPEUTICS GMBH | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2023 | Health Issues |
| HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2023 | Medicare/Medicaid, Health Issues |
| IOR PARTNERS | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2023 | Medicare/Medicaid |
| NOVOZYMES NORTH AMERICA, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q2 2023 | Health Issues |
| GENUS MEDICAL TECHNOLOGIES | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q1 2023 | Health Issues |
| HEALGEN SCIENTIFIC | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2022 | Health Issues |
| VAXART INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2022 | Health Issues |
| RAPID THERAPEUTIC SCIENCE LABORATORIES | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2022 | Health Issues |
| THE AMERICAN REGISTRY OF RADIOLOGIC TECHNOLOGISTS | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2022 | Medicare/Medicaid |
| QUORUM HEALTH CORP. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q2 2022 | Health Issues |
| BIODELIVERY SCIENCES INTERNATIONAL | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q2 2022 | Health Issues |
| AVELLINO LABS USA | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q2 2022 | Health Issues |
| NYMOX PHARMACEUTICAL CORPORATION | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q2 2022 | Health Issues |
| CODAGENIX, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q2 2022 | Health Issues, Defense |
| ACELRX PHARMACEUTICALS, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q2 2022 | Health Issues, Defense |
| ACADIA HEALTHCARE, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2021 | Health Issues |
| TERSERA THERAPEUTICS | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2021 | Medicare/Medicaid |
| GENUS LIFESCIENCES | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q2 2021 | Health Issues |
Showing the 60 most recent of 72 engagements.
| Year | Clients | Registrants |
|---|---|---|
| 2024 | 41 | 1 |
| 2023 | 41 | 1 |
| 2022 | 43 | 1 |
| 2021 | 41 | 1 |
| 2020 | 47 | 1 |
| Year | Items | Total |
|---|---|---|
| 2021 | 1 | $500 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Jodie Lockhart. See the Capitol Clarity rankings and method.